Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherContinuing Education (Invitation Only)

Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy

Hossein Jadvar and Patick M. Colletti
Journal of Nuclear Medicine Technology January 2023, jnmt.122.264928; DOI: https://doi.org/10.2967/jnmt.122.264928
Hossein Jadvar
University of Southern California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patick M. Colletti
University of Southern California, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnmt.122.264928
DOI 
https://doi.org/10.2967/jnmt.122.264928
PubMed 
36599704

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online January 4, 2023.

Article Versions

  • You are currently viewing a previous version of this article (January 4, 2023 - 12:15).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2023 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Hossein Jadvar and
  2. Patick M. Colletti
  1. University of Southern California, United States
  1. For correspondence or reprints contact: Hossein Jadvar, University of Southern California, 2250 Alcazar St, Los Angeles, California 90033, United States. E-mail: jadvar@usc.edu

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression
    Duminduni Hewa Angappulige, Nupam P. Mahajan, Kiran Mahajan
    Trends in Cancer 2024 10 4
  • Advances in PSMA Alpha Theragnostics
    Mariza Vorster, Mike Sathekge
    Seminars in Nuclear Medicine 2024 54 4
  • Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
    Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard
    Journal of Nuclear Medicine 2024 65 11
  • Enhancing Radiotherapy Sensitivity in Prostate Cancer with Lentinan-Functionalized Selenium Nanoparticles: Mechanistic Insights and Therapeutic Potential
    Yani Zou, Helin Xu, Xiu Wu, Xuesong Liu, Jianfu Zhao
    Pharmaceutics 2024 16 9
  • Strategic Advances in Combination Therapy for Metastatic Castration-Sensitive Prostate Cancer: Current Insights and Future Perspectives
    Whi-An Kwon, Yong Song, Min-Kyung Lee
    Cancers 2024 16 18
  • Clinical trials in cancer theranostics with potential near-term impact on clinical practice
    Hossein Jadvar, Abtin Doroudinia, Peter S Conti, Patrick M Colletti
    British Journal of Radiology 2025

Article usage

Article usage: January 2023 to April 2025

AbstractFullPdf
Jan 2023750022
Feb 2023423015
Mar 2023223268198
Apr 2023198213164
May 202314416892
Jun 2023846834
Jul 2023604828
Aug 20233538030
Sep 2023673925
Oct 2023583519
Nov 2023824920
Dec 2023883533
Jan 2024403218
Feb 2024473837
Mar 2024463028
Apr 2024517241
May 20243614243
Jun 2024428733
Jul 2024308637
Aug 2024287845
Sep 2024357435
Oct 2024487740
Nov 20245210131
Dec 2024326437
Jan 2025436935
Feb 20252313939
Mar 20252512553
Apr 20253811655
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy
Hossein Jadvar, Patick M. Colletti
Journal of Nuclear Medicine Technology Jan 2023, jnmt.122.264928; DOI: 10.2967/jnmt.122.264928

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy
Hossein Jadvar, Patick M. Colletti
Journal of Nuclear Medicine Technology Jan 2023, jnmt.122.264928; DOI: 10.2967/jnmt.122.264928
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
  • 2023--Looking Forward to a New Normal
  • Google Scholar

Similar Articles

Keywords

  • Oncology: GU
  • Radionuclide Therapy
  • cancer
  • PSMA
  • prostate
  • radiopharmaceutical
  • therapy
SNMMI

© 2025 SNMMI

Powered by HighWire